Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity
From MaRDI portal
Publication:5367394
DOI10.1080/01621459.2014.926815zbMath1373.62547OpenAlexW2137499396WikidataQ40543401 ScholiaQ40543401MaRDI QIDQ5367394
Peter Mueller, Juhee Lee, Peter F. Thall, Yuan Ji
Publication date: 13 October 2017
Published in: Journal of the American Statistical Association (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc4562700
adaptive designBayesian designQ-learningdynamic treatment regimephase I-II clinical trialevaluation of robustnesslatent probit model
Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Robustness and adaptive procedures (parametric inference) (62F35)
Related Items
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes, Estimating individualized treatment rules with risk constraint, Optimal Treatment Regimes: A Review and Empirical Comparison, Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies, Sequential multiple assignment randomized trial (SMART) with adaptive randomization for quality improvement in depression treatment program, A phase I-II basket trial design to optimize dose-schedule regimes based on delayed outcomes, Bayesian hierarchical random-effects meta-analysis and design of phase I clinical trials, Modeling heterogeneity in the assessment of treatment effects on tumor development while accounting for monotone dropout
